Bing

Healthcare stocks advanced 0.7% on Wall Street so far on Thursday. More broadly, the Dow Jones Industrial Average pushed 0.7% higher, the Nasdaq climbed 0.5% and the S&P 500 increased 0.7%. Some of the biggest gainers among healthcare stocks
Investor Place · 1 day ago
Healthcare Stocks
AstraZeneca plc (NYSE:AZN) was downgraded by analysts at TheStreet from a “buy” rating to a “hold” rating in a research note issued on Tuesday, MarketBeat Ratings reports. AZN has been the subject of a number of other research reports. Beaufort ...
wkrb13.com · 1 day ago
In addition to specific proprietary factors, Trade-Ideas identified AstraZeneca as such a stock due to the following factors: AZN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $75.5 million.
The Street · 1 day ago
More from Bing News
AstraZeneca plc (LON:AZN)‘s stock had its “market perform” rating reaffirmed by equities researchers at Sanford C. Bernstein in a research report issued to clients and investors on Thursday, Analyst Ratings.Net …
Ticker Report · 1 day ago
AstraZeneca is a Zacks Rank #3 (Hold) stock. Some better-ranked ranked stocks in the health care sector include Gilead Sciences Inc. GILD, Regeneron Pharmaceuticals, Inc. REGN and Valeant Pharmaceuticals International, Inc. VRX. All three hold a …
Yahoo Finance · 44 minutes ago
AstraZeneca (AZN) released its 2Q15 earnings on July 30, 2015. Driven by revenue growth from products like Crestor, Onglyza, Brilinta, and Zoladex, the company reported top-line growth at constant currencies for the …
Market Realist · 8/27/2015
AstraZeneca
Specialty-drug giant and IBD 50 stock Valeant Pharmaceuticals (NYSE:VRX) agreed to pay big pharma AstraZeneca (NYSE:AZN) up to $445 million in a licensing deal for a psoriasis drug candidate that had proved …
Investors Business Daily · ByAmy Reeves · 9/1/2015
AstraZeneca plc (LON:AZN)‘s stock had its “buy” rating reiterated by analysts at Liberum Capital in a research report issued on Friday, AnalystRatings.NET reports. AstraZeneca plc (LON:AZN) opened at 4054.00 on Friday. The stock’s market ...
sleekmoney.com · 8/23/2015
AstraZeneca currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the health care sector include Gilead Sciences Inc. GILD, Amgen and Valeant. While Valeant and Gilead are Zacks Rank #1 (Strong Buy) stocks, Amgen holds a Zacks …
NASDAQ · 9/2/2015
Shire (LSE: SHP) and AstraZeneca (LSE: AZN) are two very different companies with very different outlooks. Shire is growing rapidly and snapping up smaller peers to complement organic growth, but the company’s shares are relatively expensive.
Motley Fool UK · 9/1/2015
Shire PLC

AstraZeneca

Company
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom…
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by 2012 prescription drug sales and has operations in over 100 countries.
Data from: Wikipedia